title: Catheter-based transarterial therapies for hepatocellular cancer.
abstract: As the prevalence of liver cancer increases, so does the demand for nonsurgical, minimally invasive alternatives to surgery, since many patients have tumors that cannot be surgically resected. Catheter-based hepatic arterial procedures may be an option in patients with primary and metastatic liver cancer. The authors describe four catheter-based hepatic arterial procedures and outline the management of potential complications during the immediate postprocedural period.
authors.affiliation: Assistant Professor, Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. E-mail: Sandeep-laroia@uiowa.edu.
authors.forename: Sandeep T
authors.initials: ST
authors.lastname: Laroia
authors.affiliation: Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
authors.forename: Steven A
authors.initials: SA
authors.lastname: Morales
authors.affiliation: Assistant Professor, Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
authors.forename: Archana T
authors.initials: AT
authors.lastname: Laroia
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000098:blood supply / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004621:Embolization, Therapeutic; D006801:Humans; D008113:Liver Neoplasms / Q000098:blood supply / Q000628:therapy*; D016685:Mitomycin / Q000008:administration & dosage; D011182:Postoperative Care; D011183:Postoperative Complications; D011878:Radiotherapy; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D015021:Yttrium Radioisotopes; D016685:Mitomycin; D004317:Doxorubicin; D002945:Cisplatin